Articles with public access mandates - claudio brancoliniLearn more
OverallGovernment of ItalyAIRC Foundation for Cancer Research in ItalyNIHDFGTelethonSNSFUSEDVAHHMIAHAFWFVersus Arthritis, UKBBSRCBHFCancer Research UKMRCNational Centre for the Replacement, Refinement and Reduction of Animals in Research, UKParkinson's UKWellcomeWorldwide Cancer Research, UKDoris Duke Charitable FoundationGovernment of Spain
Not available anywhere: 4
IFNs, ISGylation and cancer: Cui prodest?
A Sgorbissa, C Brancolini
Cytokine & growth factor reviews 23 (6), 307-314, 2012
Mandates: US National Institutes of Health
Potent and selective non‐hydroxamate histone deacetylase 8 inhibitors
A Kleinschek, C Meyners, E Digiorgio, C Brancolini, FJ Meyer‐Almes
ChemMedChem 11 (23), 2598-2606, 2016
Mandates: German Research Foundation
Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
E Di Giorgio, R Benetti, E Kerschbamer, L Xodo, C Brancolini
International Review of Cell and Molecular Biology 380, 97-148, 2023
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
VKCFD2–from clinical phenotype to molecular mechanism
KJ Czogalla, M Watzka, J Oldenburg
Hämostaseologie 36 (S 02), S13-S20, 2016
Mandates: German Research Foundation
Available somewhere: 33
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ...
autophagy 17 (1), 1-382, 2021
Mandates: Swiss National Science Foundation, US National Institutes of Health, US …
Regulation of class IIa HDAC activities: it is not only matter of subcellular localization
E Di Giorgio, C Brancolini
Epigenomics 8 (2), 251-269, 2016
Mandates: Government of Italy
USP18 is a key regulator of the interferon-driven gene network modulating pancreatic beta cell inflammation and apoptosis
I Santin, F Moore, FA Grieco, P Marchetti, C Brancolini, DL Eizirik
Cell death & disease 3 (11), e419-e419, 2012
Mandates: Government of Spain
Selective class IIa HDAC inhibitors: myth or reality
E Di Giorgio, E Gagliostro, C Brancolini
Cellular and molecular life sciences 72, 73-86, 2015
Mandates: Government of Italy
The histone code of senescence
H Paluvai, E Di Giorgio, C Brancolini
Cells 9 (2), 466, 2020
Mandates: Government of Italy
The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase
E Di Giorgio, E Gagliostro, A Clocchiatti, C Brancolini
Molecular and cellular biology, 2015
Mandates: Government of Italy
MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation
E Di Giorgio, A Clocchiatti, S Piccinin, A Sgorbissa, G Viviani, P Peruzzo, ...
Molecular and cellular biology 33 (22), 4473-4491, 2013
Mandates: Government of Italy
The co-existence of transcriptional activator and transcriptional repressor MEF2 complexes influences tumor aggressiveness
E Di Giorgio, E Franforte, S Cefalù, S Rossi, AP Dei Tos, M Brenca, ...
PLoS genetics 13 (4), e1006752, 2017
Mandates: Government of Italy
Different class IIa HDACs repressive complexes regulate specific epigenetic responses related to cell survival in leiomyosarcoma cells
E Di Giorgio, E Dalla, E Franforte, H Paluvai, M Minisini, M Trevisanut, ...
Nucleic Acids Research 48 (2), 646-664, 2020
Mandates: AIRC Foundation for Cancer Research in Italy
HDAC4 degradation during senescence unleashes an epigenetic program driven by AP-1/p300 at selected enhancers and super-enhancers
E Di Giorgio, H Paluvai, E Dalla, L Ranzino, A Renzini, V Moresi, ...
Genome Biology 22, 1-25, 2021
Mandates: Government of Italy
Synthesis, characterization, and optimization for in vivo delivery of a nonselective isopeptidase inhibitor as new antineoplastic agent
U Cersosimo, A Sgorbissa, C Foti, S Drioli, R Angelica, A Tomasella, ...
Journal of medicinal chemistry 58 (4), 1691-1704, 2015
Mandates: Government of Italy
A receptor-interacting protein 1 (RIP1)-independent necrotic death under the control of protein phosphatase PP2A that involves the reorganization of actin cytoskeleton and the …
A Tomasella, A Blangy, C Brancolini
Journal of Biological Chemistry 289 (37), 25699-25710, 2014
Mandates: Government of Italy
HDACs and the epigenetic plasticity of cancer cells: Target the complexity
C Brancolini, T Gagliano, M Minisini
Pharmacology & therapeutics 238, 108190, 2022
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Characterization of caspase-dependent and caspase-independent deaths in glioblastoma cells treated with inhibitors of the ubiquitin-proteasome system
C Foti, C Florean, A Pezzutto, P Roncaglia, A Tomasella, S Gustincich, ...
Molecular cancer therapeutics 8 (11), 3140-3150, 2009
Mandates: US National Institutes of Health
Quis custodiet ipsos custodes (who controls the controllers)? Two decades of studies on HDAC9
C Brancolini, E Di Giorgio, L Formisano, T Gagliano
Life 11 (2), 90, 2021
Mandates: Government of Italy
Transformation by different oncogenes relies on specific metabolic adaptations
P Peruzzo, M Comelli, E Di Giorgio, E Franforte, I Mavelli, C Brancolini
Cell Cycle 15 (19), 2656-2668, 2016
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program